Sol-Gel Technologies Ltd. (SLGL)
Last updated: 2026-10-21 23:56:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Summary
Sol-Gel Technologies Ltd. (SLGL) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $65.63, with a market capitalization of $212.74M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $28.81 to $97.97. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$212.74M | |
$66.44 | |
$210.00 | |
$3.34 | |
$65.81 | |
57.84K | |
53.99K | |
-- | |
$97.97 | |
$28.81 | |
-- | |
-- |
Sol-Gel Technologies Ltd. (SLGL) After-Hours Stock Price
Sol-Gel Technologies Ltd. (SLGL) is trading at $66.71 in after-hours trading as of 2026-10-21 23:31:00, up 1.37% ($0.90) from the regular-session close of $65.81.
After-hours trading shows how investors are pricing SLGL after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Sol-Gel Technologies Ltd. (SLGL) 7-Day Stock Price Change
Over the past seven days, Sol-Gel Technologies Ltd. (SLGL) moved from $72.40 to $65.63, representing a decline of 9.35% ($6.77).
The stock traded between $62.66 and $73.11 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 37.55 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
SLGL 52-Week Price Position
Position in Range: 53.2%
SLGL is currently trading at $65.63, placing it 53.2% of the way from its 52-week low of $28.81 to its 52-week high of $97.97. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Sol-Gel Technologies Ltd. (SLGL)?
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.
Sol-Gel Technologies Ltd. Information
| Employees | 28 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Sol-Gel Technologies Ltd. (SLGL) Stock on MEXC
Eligible investors can buy real shares of Sol-Gel Technologies Ltd. (SLGL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Sol-Gel Technologies Ltd. (SLGL) stock price today?
2.Is SLGL stock going up or down today?
3.What is SLGL pre-market price?
4.What is SLGL after-hours price?
5.Is SLGL stock trading now?
6.Where does SLGL sit relative to its 52-week high and low?
7.What sector is Sol-Gel Technologies Ltd. in?
8.What is Sol-Gel Technologies Ltd.'s market capitalization and where is it listed?
9.How is SLGL valued in terms of P/E ratio and EPS?
10.Does Sol-Gel Technologies Ltd. pay a dividend?
Explore More US Stocks
Search Stocks
SLGL Stock Calculator
Estimate the value between SLGL shares and USD.
SLGL Shares to USD
1.00 SLGL shares = 65.632 USD
Calculations are estimates based on the latest available price and are for reference only.


